trending Market Intelligence /marketintelligence/en/news-insights/trending/fqcOC3jUXC9TLmwE1cpKPg2 content esgSubNav
In This List

Astorg backs clinical trial tech platform eResearch

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

Banking Essentials Newsletter: July Edition - Part 2

Blog

Anticipate the Unknown Go Beyond Fundamentals to Uncover Early Signs of Private Company Credit Deterioration


Astorg backs clinical trial tech platform eResearch

French private equity firm Astorg Partners invested an undisclosed amount in U.S.-based clinical trial technology company, eResearchTechnology Inc., or ERT.

ERT's management team and existing shareholders Nordic Capital and Novo Holdings A/S will reinvest in the company alongside Astorg. Nordic initially invested in the Philadelphia-based data company through its Fund VIII and will reinvest through its Fund IX.

Completion of the transaction is subject to approvals from relevant antitrust authorities.